Clearstead Advisors’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.8K Hold
583
﹤0.01% 1695
2026
Q1
$25.5K Sell
583
-616
-51% -$28.1K ﹤0.01% 1397
2025
Q4
$53.2K Buy
1,199
+663
+124% +$28.6K ﹤0.01% 1383
2025
Q3
$22.6K Buy
536
+100
+23% +$4.03K ﹤0.01% 1591
2025
Q2
$16K Sell
436
-772
-64% -$28.7K ﹤0.01% 1721
2025
Q1
$46K Buy
1,208
+1,164
+2,645% +$43.3K ﹤0.01% 1192
2024
Q4
$1.67K Buy
44
+3
+7% +$120 ﹤0.01% 1870
2024
Q3
$1.69K Hold
41
﹤0.01% 1855
2024
Q2
$1.4K Buy
41
+1
+3% +$31 ﹤0.01% 1865
2024
Q1
$1.23K Buy
40
+1
+3% +$30 ﹤0.01% 1378
2023
Q4
$1.2K Sell
39
-37
-49% -$1.19K ﹤0.01% 1381
2023
Q3
$2.53K Sell
76
-4,232
-98% -$135K ﹤0.01% 1368
2023
Q2
$132K Hold
4,308
0.01% 511
2023
Q1
$118K Buy
4,308
+1
+0% +$28 0.01% 482
2022
Q4
$120K Buy
4,307
+1
+0% +$30 0.01% 465
2022
Q3
$127K Buy
+4,306
New +$135K 0.01% 429
2022
Q1
Sell
-392
Closed -$12K 1437
2021
Q4
$12K Hold
392
﹤0.01% 913
2021
Q3
$12K Buy
+392
New +$13.5K ﹤0.01% 921

Other funds holding OHI

Clearstead Advisors's OHI Position: Q2 2026 in Review

Clearstead Advisors held its Omega Healthcare (OHI) position steady in Q2 2026 at 583 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1695.

Clearstead Advisors first reported a position in OHI in Q3 2021 and has held it in 18 quarters since. The position peaked at $132K in Q2 2023. 442 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Clearstead Advisors held 583 shares of Omega Healthcare worth $27.8K as of Q2 2026.
  • Clearstead Advisors left its Omega Healthcare share count unchanged in Q2 2026.
  • Omega Healthcare made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1695 holding.
  • Clearstead Advisors first reported a position in Omega Healthcare in Q3 2021 and has held it in 18 quarters since.
  • Clearstead Advisors's Omega Healthcare position peaked at $132K in Q2 2023.
  • 442 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.